|
1
|
Yang X, Zhang D, Liu S, Li X, Hu W and Han
C: KLF4 suppresses the migration of hepatocellular carcinoma by
transcriptionally upregulating monoglyceride lipase. Am J Cancer
Res. 8:1019–1029. 2018.PubMed/NCBI
|
|
2
|
Xie Y: Hepatitis B virus-associated
hepatocellular carcinoma. Adv Exp Med Biol. 1018:11–21. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xing H, Qiu H, Ding X, Han J, Li Z, Wu H,
Yan C, Li H, Han R, Zhang H, et al: Clinical performance of
alpha-L-fucosidase for early detection of hepatocellular carcinoma.
Biomark Med. 13:545–555. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiao D, Li Y, Yang F, Han D, Wu J, Shi S,
Tian F, Guo Z, Xi W, Li G, et al: Expression of prostate-specific
membrane antigen in tumor-associated vasculature predicts poor
prognosis in hepatocellular carcinoma. Clin Transl Gastroenterol.
May 15–2019.doi: 10.14309/ctg.0000000000000041 (Online ahead of
print). View Article : Google Scholar
|
|
5
|
Xiao Z, Yan Y, Zhou Q, Liu H, Huang P,
Zhou Q, Lai C, Zhang J, Wang J and Mao K: Development and external
validation of prognostic nomograms in hepatocellular carcinoma
patients: A population based study. Cancer Manag Res. 11:2691–2708.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koboldt DC, Zhang Q, Larson DE, Shen D,
McLellan MD, Lin L, Miller CA, Mardis ER, Ding L and Wilson RK:
VarScan 2: Somatic mutation and copy number alteration discovery in
cancer by exome sequencing. Genome Res. 22:568–576. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ziats MN and Rennert OM: Identification of
differentially expressed microRNAs across the developing human
brain. Mol Psychiatry. 19:848–852. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye
QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade's studies on
metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol.
130:187–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sells MA, Chen ML and Acs G: Production of
hepatitis B virus particles in Hep G2 cells transfected with cloned
hepatitis B virus DNA. Proc Natl Acad Sci USA. 84:1005–1009. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakabayashi H, Taketa K, Miyano K, Yamane
T and Sato J: Growth of human hepatoma cells lines with
differentiated functions in chemically defined medium. Cancer Res.
42:3858–3863. 1982.PubMed/NCBI
|
|
11
|
Schulze K, Nault JC and Villanueva A:
Genetic profiling of hepatocellular carcinoma using next-generation
sequencing. J Hepatol. 65:1031–1042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin Y, Lee WY, Toh ST, Tennakoon C, Toh
HC, Chow PK, Chung AY, Chong SS, Ooi LL, Sung WK and Lee CG:
Comprehensive analysis of transcriptome profiles in hepatocellular
carcinoma. J Transl Med. 17:2732019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY,
Chen J and Xue Q: New human hepatocellular carcinoma (HCC) cell
line with highly metastatic potential (MHCC97) and its expressions
of the factors associated with metastasis. Br J Cancer. 81:814–821.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue
Q, Chen J, Gao DM and Bao WH: Establishment of cell clones with
different metastatic potential from the metastatic hepatocellular
carcinoma cell line MHCC97. World J Gastroenterol. 7:630–636. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kan Z, Zheng H, Liu X, Li S, Barber TD,
Gong Z, Gao H, Hao K, Willard MD, Xu J, et al: Whole-genome
sequencing identifies recurrent mutations in hepatocellular
carcinoma. Genome Res. 23:1422–1433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen D, Li Z, Song Q, Qian L, Xie B and
Zhu J: Clinicopathological features and differential diagnosis of
hepatocellular carcinoma in extrahepatic metastases. Medicine
(Baltimore). 97:e133562018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He ZX, Xiang P, Gong JP, Cheng NS and
Zhang W: Radiofrequency ablation versus resection for Barcelona
clinic liver cancer very early/early stage hepatocellular
carcinoma: A systematic review. Ther Clin Risk Manag. 12:295–303.
2016.PubMed/NCBI
|
|
19
|
Tejeda-Maldonado J, García-Juárez I,
Aguirre-Valadez J, González-Aguirre A, Vilatobá-Chapa M,
Armengol-Alonso A, Escobar-Penagos F, Torre A, Sánchez-Ávila JF and
Carrillo-Pérez DL: Diagnosis and treatment of hepatocellular
carcinoma: An update. World J Hepatol. 7:362–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khordadmehr M, Jigari-Asl F, Ezzati H,
Shahbazi R, Sadreddini S, Safaei S and Baradaran B: A comprehensive
review on miR-451: A promising cancer biomarker with therapeutic
potential. J Cell Physiol. 234:21716–21731. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mirza AZ: Advancement in the development
of heterocyclic nucleosides for the treatment of cancer-A review.
Nucleosides Nucleotides Nucleic Acids. 38:836–857. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nwabo Kamdje AH, Takam Kamga P, Tagne Simo
R, Vecchio L, Seke Etet PF, Muller JM, Bassi G, Lukong E, Kumar
Goel R, Mbo Amvene J and Krampera M: Developmental pathways
associated with cancer metastasis: Notch, Wnt, and Hedgehog. Cancer
Biol Med. 14:109–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Banelli B, Bonassi S, Casciano I, Mazzocco
K, Di Vinci A, Scaruffi P, Brigati C, Allemanni G, Borzì L, Tonini
GP and Romani M: Outcome prediction and risk assessment by
quantitative pyrosequencing methylation analysis of the SFN gene in
advanced stage, high-risk, neuroblastic tumor patients. Int J
Cancer. 126:656–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clarke JD, Dashwood RH and Ho E:
Multi-targeted prevention of cancer by sulforaphane. Cancer Lett.
269:291–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh SV, Herman-Antosiewicz A, Singh AV,
Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R:
Sulforaphane-induced G2/M phase cell cycle arrest involves
checkpoint kinase 2-mediated phosphorylation of cell division cycle
25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steiner M, Clark B, Tang JZ, Zhu T and
Lobie PE: 14-3-3σ mediates G2-M arrest produced by
5-aza-2′-deoxycytidine and possesses a tumor suppressor role in
endometrial carcinoma cells. Gynecol Oncol. 127:231–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thangapandiyan S, Ramesh M, Hema T,
Miltonprabu S, Uddin MS, Nandhini V and Bavithra Jothi G:
Sulforaphane potentially ameliorates arsenic induced hepatotoxicity
in albino Wistar rats: Implication of PI3K/Akt/Nrf2 signaling
pathway. Cell Physiol Biochem. 52:1203–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Y, Xue K, Li Z, Zheng W, Dong W, Song
J, Sun S, Ma T and Li W: c-Myc regulates the CDK1/cyclin B1
dependentG2/M cell cycle progression by histone H4 acetylation in
Raji cells. Int J Mol Med. 41:3366–3378. 2018.PubMed/NCBI
|
|
30
|
Wang J, Chang L, Lai X, Li X, Wang Z,
Huang Z, Huang J and Zhang G: Tetrandrine enhances radiosensitivity
through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal
carcinoma cells. Cell Cycle. 17:671–680. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jang SH, Kim AR, Park NH, Park JW and Han
IS: DRG2 regulates G2/M progression via the cyclin B1-cdk1 Complex.
Mol Cells. 39:699–704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang Y, Yu H, Liang X, Xu J and Cai X:
Chk1-induced CCNB1 overexpression promotes cell proliferation and
tumor growth in human colorectal cancer. Cancer Biol Ther.
15:1268–1279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Chen YL, Xie YT, Zheng LY, Han JY,
Wang H, Tian XX and Fang WG: Association study of germline variants
in CCNB1 and CDK1 with breast cancer susceptibility, progression,
and survival among Chinese Han women. PLoS One. 8:e844892013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song GQ and Zhao Y: MicroRNA-211, a direct
negative regulator of CDC25B expression, inhibits triple-negative
breast cancer cells' growth and migration. Tumour Biol.
36:5001–5009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Q, Shi R, Wang X, Li D, Wu H and Ren
B: Overexpression of ZIC5 promotes proliferation in non-small cell
lung cancer. Biochem Biophys Res Commun. 479:502–509. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi Q, Wang W, Jia Z, Chen P, Ma K and
Zhou C: ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes,
promotes gastric cancer cell proliferation and tumor growth.
Oncotarget. 7:36489–36500. 2016. View Article : Google Scholar : PubMed/NCBI
|
